BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, June 4, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 15, 2021
View Archived Issues
Preclinical data presented for HIF-1 inhibitor LW-1564
Read More
EPRS inhibitor DWN-12088 shows antifibrotic effects in vitro and in vivo
Read More
Mitochondrial-encoded MOTS-c as novel therapeutic target in autoimmune diabetes
Read More
Bahcesehir Universitesi presents new Hdm2 inhibitors
Read More
CD39+ plasmablasts and adenosine identified as drivers of sepsis-induced long-term immunosuppression
Read More
JUN identified as a crucial regulator of pathological skin scarring via CD36
Read More
ZDWX-25, GSK-3beta/DYRK1A dual inhibitor with promising activity in models of AD
Read More
A subset of EGFR-mutant, MET-amplified lung cancers relies only on MET activation for survival
Read More
AZD-0095, selective MCT4 inhibitor with excellent potency in cancer models
Read More
Latrophilin-3 induces urothelial tumorigenesis and is a therapeutic target
Read More
Targeting late inflammation via complement system ameliorates TBI-induced epilepsy
Read More
Mindset Pharma shows MSP-1014 is comparable to psilocybin in drug discrimination assay
Read More
eIF4A3 identified as possible therapeutic target for cancer
Read More
U.S. researchers patent new compounds for malaria
Read More
Theseus Pharmaceuticals divulges EGFR mutant inhibitors
Read More
Vipergen and PhoreMost enter into multitarget drug discovery agreement
Read More
D-dimer predicts reduced DLCO in COVID-19-associated pneumonia
Read More
